英国早产儿视网膜病变的筛查和治疗指南2022更新版解读

doi:10.7499/j.issn.1008-8830.2311073

摘要
图/表
参考文献(31)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (590 KB) [HTML]
输出: BibTeX | EndNote (RIS) 背景资料

摘要英国早产儿视网膜病变的筛查和治疗指南2022更新版由英国皇家儿科与儿童健康学院和皇家眼科学院的多学科指南制订小组按照英国国家卫生与临床优化研究所标准制订，于2022年3月发表在英国皇家儿科与儿童健康学院网站和皇家眼科学院网站，2023年3月在Early Human Development杂志正式发表。该指南对早产儿视网膜病变的筛查及治疗进行了循证推荐和建议。与更新前的指南相比，2022更新版最重要的变化是将胎龄筛查标准降至31周以下；治疗部分涵盖了早产儿视网膜病变的治疗适应证、时间、方法及随诊。该文对该指南进行解读并与国内早产儿视网膜病变指南/共识进行比较，为国内同行提供参考和借鉴。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	董晓燕
	李嘉知
	罗可人
	唐军
	母得志

关键词 ：视网膜病变, 筛查, 治疗, 指南, 早产儿

Abstract：The UK screening and treatment of retinopathy of prematurity (ROP) updated 2022 guidelines were developed by a multidisciplinary guideline development group from the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists, following the standards of the National Institute for Health and Care Excellence. They were published on the websites of the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists in March 2022, and formally published in Early Human Development in March 2023. The guidelines provide evidence-based recommendations for the screening and treatment of ROP. The most significant change in the 2022 updated version compared to the previous guidelines is the lowering of the gestational age screening criterion to below 31 weeks. The treatment section covers treatment indications, timing, methods, and follow-up visits of ROP. This article interprets the guidelines and compares them with ROP guidelines/consensus in China, providing a reference for domestic peers.

Key words： Retinopathy Screening Treatment Guideline Premature infant

收稿日期: 2023-11-15

基金资助:国家自然科学基金项目（82171710）。

通讯作者: 唐军，女，主任医师，教授。Email：tj1234753@sina.com。 E-mail: tj1234753@sina.com

作者简介: 董晓燕，女，硕士研究生；

引用本文:

董晓燕,李嘉知,罗可人等. 英国早产儿视网膜病变的筛查和治疗指南2022更新版解读[J]. 中国当代儿科杂志, 2024, 26(5): 437-443.

DONG Xiao-Yan,LI Jia-Zhi,LUO Ke-Ren et al. Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines[J]. CJCP, 2024, 26(5): 437-443.

链接本文:

http://www.zgddek.com/CN/10.7499/j.issn.1008-8830.2311073 或 http://www.zgddek.com/CN/Y2024/V26/I5/437

	Wilkinson AR, Adams GGW, Fleck BW, et al. UK screening and treatment of retinopathy of prematurity updated 2022 guidelines[J]. Early Hum Dev, 2023: 177-178: 105715. PMID: 36780724. DOI: 10.1016/j.earlhumdev.2023.105715.
	2 Royal College of Paediatrics and Child Health. Screening of retinopathy of prematurity (ROP): clinical guideline[EB/OL]. [2023-11-15]. https://www.rcpch.ac.uk/resources/screening-retinopathy-prematurity-rop-clinical-guideline.
	3 The Royal College of Ophthalmologists. Treating retinopathy of prematurity in the UK[EB/OL]. (2022-03-21)[2023-11-15]. https://www.rcophth.ac.uk/resources-listing/uk-retinopathy-of-prematurity-guideline/.
	4 Scottish Intercollegiate Guidelines Network. A Guideline Developer's Handbook[EB/OL]. [2023-11-15]. https://www.sign.ac.uk/media/2038/sign50_2019.pdf.
	Wilkinson AR, Haines L, Head K, et al. UK retinopathy of prematurity guideline[J]. Early Hum Dev, 2008, 84(2): 71-74. PMID: 18280404. DOI: 10.1016/j.earlhumdev.2007.12.004.
	6 中华医学会眼科学分会眼底病学组. 中国早产儿视网膜病变筛查指南（2014年）[J]. 中华眼科杂志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
	7 中华医学会儿科学分会眼科学组. 早产儿视网膜病变治疗规范专家共识[J]. 中华眼底病杂志, 2022, 38(1): 10-13. DOI: 10.3760/cma.j.cn511434-20211119-00647.
	8 中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病专委会. 中国早产儿视网膜病变分类和治疗专家共识（2023年）[J]. 中华眼底病杂志, 2023, 39(9): 720-727. DOI: 10.3760/cma.j.cn511434-20230815-00346.
	Adams GG, Bunce C, Xing W, et al. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk[J]. BMJ Open, 2017, 7(3): e013366. PMID: 28325857. PMCID: PMC5372114. DOI: 10.1136/bmjopen-2016-013366.
	Adams GGW, Williams C, Modi N, et al. Can we reduce the burden of the current UK guidelines for retinopathy of prematurity screening?[J]. Eye (Lond), 2018, 32(2): 235-237. PMID: 28799564. PMCID: PMC5811691. DOI: 10.1038/eye.2017.163.
	Reynolds JD, Dobson V, Quinn GE, et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies[J]. Arch Ophthalmol, 2002, 120(11): 1470-1476. PMID: 12427059. DOI: 10.1001/archopht.120.11.1470.
	Austeng D, K?llen KB, Hellstr?m A, et al. Natural history of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden[J]. Arch Ophthalmol, 2010, 128(10): 1289-1294. PMID: 20937998. DOI: 10.1001/archophthalmol.2010.234.
	Miller MM, Revenis ME, Lai MM, et al. Risk and clinical course of retinopathy of prematurity in 78 infants of gestational age 22-25 weeks[J]. J AAPOS, 2014, 18(3): 266-270. PMID: 24924282. PMCID: PMC4137242. DOI: 10.1016/j.jaapos.2014.01.016.
	Aikawa H, Noro M. Low incidence of sight-threatening retinopathy of prematurity in infants born before 28 weeks gestation at a neonatal intensive care unit in Japan[J]. Tohoku J Exp Med, 2013, 230(3): 185-190. PMID: 23883589. DOI: 10.1620/tjem.230.185.
	Isaza G, Arora S. Incidence and severity of retinopathy of prematurity in extremely premature infants[J]. Can J Ophthalmol, 2012, 47(3): 296-300. PMID: 22687311. DOI: 10.1016/j.jcjo.2012.03.027.
	Kennedy KA, Wrage LA, Higgins RD, et al. Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infants[J]. J Perinatol, 2014, 34(4): 311-318. PMID: 24503911. PMCID: PMC3969774. DOI: 10.1038/jp.2014.12.
	Fukushima Y, Kawasaki R, Sakaguchi H, et al. Characterization of the progression pattern in retinopathy of prematurity subtypes[J]. Ophthalmol Retina, 2020, 4(3): 231-237. PMID: 31982389. DOI: 10.1016/j.oret.2019.11.015.
	Sloane AJ, O'Donnell EA, Mackley AB, et al. Do extremely preterm infants need retinopathy of prematurity screening earlier than 31 weeks postmenstrual age?[J]. J Perinatol, 2021, 41(2): 305-309. PMID: 32377010. DOI: 10.1038/s41372-020-0681-6.
	Quinn GE, Ying GS, Bell EF, et al. Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal growth and retinopathy of prematurity (G-ROP) study[J]. JAMA Ophthalmol, 2018, 136(12): 1383-1389. PMID: 30326046. PMCID: PMC6583045. DOI: 10.1001/jamaophthalmol.2018.4290.
	20 张国明, 李娜, 张福燕. 早产儿视网膜病变和足月新生儿眼病筛查指南[J]. 眼科新进展, 2014, 34(2): 101-107. DOI: 10.13389/j.cnki.rao.2014.0027.
	Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial[J]. Arch Ophthalmol, 2003, 121(12): 1684-1694. PMID: 14662586. DOI: 10.1001/archopht.121.12.1684.
	The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group[J]. Arch Ophthalmol, 1994, 112(7): 903-912. PMID: 8031269. DOI: 10.1001/archopht.1994.01090190051021.
	Repka MX, Palmer EA, Tung B. Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group[J]. Arch Ophthalmol, 2000, 118(5): 645-649. PMID: 10815156. DOI: 10.1001/archopht.118.5.645.
	Dhaliwal C, Wright E, Graham C, et al. Wide-field digital retinal imaging versus binocular indirect ophthalmoscopy for retinopathy of prematurity screening: a two-observer prospective, randomised comparison[J]. Br J Ophthalmol, 2009, 93(3): 355-359. PMID: 19028742. DOI: 10.1136/bjo.2008.148908.
	Photographic Screening for Retinopathy of Prematurity (Photo-ROP) Cooperative Group. The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes[J]. Retina, 2008, 28(3 Suppl): S47-S54. PMID: 18317345. DOI: 10.1097/IAE.0b013e31815e987f.
	Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial[J]. Trans Am Ophthalmol Soc, 2004, 102: 233-248. PMID: 15747762. PMCID: PMC1280104.
	Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity[J]. N Engl J Med, 2011, 364(7): 603-615. PMID: 21323540. PMCID: PMC3119530. DOI: 10.1056/NEJMoa1007374.
	Stahl A, Lepore D, Fielder A, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial[J]. Lancet, 2019, 394(10208): 1551-1559. PMID: 31522845. DOI: 10.1016/S0140-6736(19)31344-3.
	Gilbert WS, Quinn GE, Dobson V, et al. Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group[J]. Arch Ophthalmol, 1996, 114(9): 1085-1091. PMID: 8790093. DOI: 10.1001/archopht.1996.01100140287005.
	Singh R, Reddy DM, Barkmeier AJ, et al. Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity[J]. Br J Ophthalmol, 2012, 96(11): 1395-1398. PMID: 22923456. DOI: 10.1136/bjophthalmol-2011-301353.
	Karacorlu M, Hocaoglu M, Sayman Muslubas I, et al. Long-term functional results following vitrectomy for advanced retinopathy of prematurity[J]. Br J Ophthalmol, 2017, 101(6): 730-734. PMID: 27635064. DOI: 10.1136/bjophthalmol-2016-309198.